Search results

451. Efficiency biomarkers in photodynamic therapy against lung cancer

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: PRELUDIUM 2, Panel: NZ4

452. Synthesis of new phthalocyanines for targeted photodynamic cancer therapy.

Principal investigator: dr Łukasz Andrzej Łapok

Uniwersytet Jagielloński, Wydział Chemii; Zespół Nanotechnologii Polimerów i Biomateriałów

Call: SONATA 2, Panel: ST5

453. Study of the role of GRHL1 transcription factor in mechanisms of development of skin cancers and in cellular signaling p…

Principal investigator: Michał Krzysztof Mlącki

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: PRELUDIUM 2, Panel: NZ3

454. Biomedical and chemometric assessment of the new analytical platform in the study of endogenous substances as potential …

Principal investigator: dr Lucyna Konieczna

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

Call: OPUS 2, Panel: NZ7

455. New synthetic resveratrol derivatives with potential anti-ageing and anti-cancer properties

Principal investigator: dr Justyna Mikuła-Pietrasik

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

Call: PRELUDIUM 2, Panel: NZ7

456. Identification of breast cancer cells death and senescence mechanisms induction resulting from telomerase silencing with…

Principal investigator: dr hab. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: OPUS 2, Panel: NZ7

457. CD200R signaling in infmallation and immune cancer responses: a tricky balance

Principal investigator: dr Tomasz Piotr Rygiel

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Call: SONATA 2, Panel: NZ6

458. Comparison of the mechanism of action of valproic acid and levetiracetam as histone deacetylase inhibitors in ovarian ca…

Principal investigator: Patrycja Katarzyna Kwiecińska

Uniwersytet Jagielloński, Wydział Biologii i Nauk o Ziemi

Call: PRELUDIUM 2, Panel: NZ7

459. Cytotoxic conjugates targeting FGFR-related cancers based on FGF1 and FGFR-specific antibodies.

Principal investigator: prof. Jacek Józef Otlewski

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: MAESTRO 1, Panel: NZ1

460. Early molecular mechanisms in invasive colon cancer cells induced by Snail controlled genes

Principal investigator: prof. Maria Anna Kowalska

Instytut Biologii Medycznej PAN

Call: MAESTRO 1, Panel: NZ3

461. IREB2 and FAM13A as a chronic obstructive pulmonary disease and lung cancer susceptibility genes: genetic-association an…

Principal investigator: dr Iwona Maria Ziółkowska-Suchanek

Instytut Genetyki Człowieka PAN

Call: SONATA 1, Panel: NZ5

462. An evaluation of the incidence and clinical importance of micrometastases and isolated tumor cells within the lymphatic …

Principal investigator: dr Arkadiusz Andrzej Spychała

Wielkopolskie Centrum Onkologii

Call: PRELUDIUM 1, Panel: NZ4

463. Oxygen concentration as regulator of proliferation and survival of renal cancer stem cells

Principal investigator: prof. Cezary Adam Szczylik

Wojskowy Instytut Medyczny

Call: OPUS 1, Panel: NZ5

464. Molecular basis of betaglycan deregulation in endomatrial cancer

Principal investigator: Piotr Kamil Zakrzewski

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 1, Panel: NZ4

465. The study of new synthetic triterpens anticancer activity at the level of autophagy induction and modulation of adhesion…

Principal investigator: dr Natalia Magdalena Lisiak

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: PRELUDIUM 1, Panel: NZ4

466. Analysis of protein mass profiles obtained by MALDI-ToF spectrometry to discover signatures of cancer

Principal investigator: dr Michał Marczyk

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

Call: PRELUDIUM 1, Panel: NZ2

467. Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

Principal investigator: prof. Tadeusz Andrzej Holak

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 1, Panel: ST5

468. Genome abberations, p53 status and nitrosative-oxidative stress manifestation during establishment of methotrexate-induc…

Principal investigator: dr hab. Magdalena Dąbrowska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 1, Panel: NZ4

469. DNA methylation and microRNA expression profiling in different types of cancer

Principal investigator: dr hab. Izabela Elżbieta Zawlik

Uniwersytet Rzeszowski

Call: OPUS 1, Panel: NZ4

470. Analysis of interleukin 6 and its soluble receptor involvement in signaling renal cancer cells - metastatic organ cell

Principal investigator: prof. Cezary Adam Szczylik

Wojskowy Instytut Medyczny

Call: OPUS 1, Panel: NZ4

471. Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms…

Principal investigator: dr Wojciech Stanisław Placha

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: SONATA 1, Panel: NZ4

472. Feasibility of personalized adiuvant chemotherapy of gastric cancer utilizing expression profiling, polymorphism and met…

Principal investigator: dr hab. Piotr Kołodziejczyk

Uniwersytet Jagielloński- Collegium Medicum, Wydział Lekarski

Call: OPUS 1, Panel: NZ4

473. Analyses of the interactions between prostate cancer, immune and endothelial cells within metastatic cell niche"

Principal investigator: dr hab. Jarosław Piotr Czyż

Uniwersytet Jagielloński

Call: OPUS 1, Panel: NZ3

474. Integrative analysis of tRNA modification circuits and aminoacylation and their role in breast cancer model.

Principal investigator: dr Marcin Sajek

Instytut Genetyki Człowieka PAN

Call: OPUS 29, Panel: NZ2

475. Role of the BRM- ERα interaction in the conferring of resistance to paclitaxel in BRG1-deficient cancers

Principal investigator: Karolina Gronkowska

Uniwersytet Łódzki

Call: PRELUDIUM 24, Panel: NZ7

476. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor…

Principal investigator: Weronika Wojtyś

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 24, Panel: NZ4

477. UVC Persistent Phosphors for Next-Generation Photodynamic Cancer Therapy

Principal investigator: dr Nadiia Rebrova

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

Call: OPUS 29, Panel: ST4

478. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

Principal investigator: Joanna Irena Szechyńska

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: PRELUDIUM 24, Panel: ST11

479. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d…

Principal investigator: dr Krzysztof Bartnik

Politechnika Warszawska

Call: SONATINA 9, Panel: NZ7

480. Aptamer-mediated SERS/DEP Biosensors for proteomic analysis of extracellular vesicles of salivary gland tumors: towards …

Principal investigator: prof. Agnieszka Edyta Michota-Kamińska

Instytut Chemii Fizycznej Polskiej Akademii Nauk

Call: OPUS 28, Panel: ST4

481. Supramolecular nanoparticles able to block calcium channels in cancer cells

Principal investigator: dr hab. Marek Brzeziński

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: SONATA BIS 14, Panel: ST11

482. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti…

Principal investigator: Aleksandra Dorota Helbik-Maciejewska

Uniwersytet Gdański

Call: PRELUDIUM 23, Panel: ST5

483. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

Principal investigator: Dominik Jakub Dreszer

UNIWERSYTET ŚLĄSKI

Call: PRELUDIUM 23, Panel: NZ7

484. Vascular dysfunction after breast cancer neoadjuvant chemotherapy.The significance of menopausal status and estrogens.

Principal investigator: dr Piotr Szczepaniak

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA 19, Panel: NZ4

485. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen…

Principal investigator: prof. Ryszard Józef Ostaszewski

Instytut Chemii Organicznej Polska Akademia Nauk

Call: OPUS 25, Panel: NZ7

486. The design and development of the peptide inhibitors library targeting Zn(II)-binding site of matrix metalloproteinases …

Principal investigator: Paulina Alicja Potok

Uniwersytet Wrocławski, Wydział Chemii

Call: PRELUDIUM 22, Panel: ST5

487. Functional consequences of loss of chromosome Y (LOY) in immune cells in the context of cancer - ex vivo and in vitro st…

Principal investigator: dr Jan Dumański

Gdański Uniwersytet Medyczny, Międzynarodowa Agenda Badawcza

Call: OPUS 25, Panel: NZ2

488. 3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s…

Principal investigator: prof. Edyta Proniewicz

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

Call: OPUS 25, Panel: ST4

489. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: SONATA 18, Panel: NZ7

490. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

Principal investigator: prof. Rafał Artur Bartoszewski

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 24, Panel: NZ7

491. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Call: POLONEZ BIS 3, Panel: NZ5

492. Oncogene competition - a new interplay mechanism of mutant p53 with CMYC and mutant KRAS in human cancers.

Principal investigator: dr hab. Dawid Włodzimierz Walerych

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 23, Panel: NZ5

493. Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

Principal investigator: Magdalena Alicja Strachowska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 21, Panel: NZ5

494. Theranostic oxygen nanobubbles for cancer radiotherapy enhancement and perfusion imaging

Principal investigator: dr hab. Martyna Elas

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 23, Panel: NZ4

495. Sensitive detection and visualization of cancer biomarkers using upconversion nanoparticles excited above 1000 nm

Principal investigator: dr Natalia Maria Jurga

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: PRELUDIUM 21, Panel: ST4

496. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

Principal investigator: dr Anna Katarzyna Florczak-Substyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 17, Panel: NZ7

497. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA 17, Panel: NZ7

498. Extracellular vesicles modified ex vivo as an anti-cancer immune-response boosting vaccine

Principal investigator: Klaudia Elżbieta Kiel

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 20, Panel: NZ6

499. Influence of indyvidual low-dose radiosensitivity on the chemopotentiating effect of low-dose fractionated radiation in …

Principal investigator: dr hab. Dorota Słonina

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: PRELUDIUM BIS 2, Panel: NZ5

500. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R…

Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

Uniwersytet w Białymstoku, Wydział Chemii

Call: OPUS 20, Panel: ST4

Projects search